Clinical Trial Update: Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating intensive glycemic control in patients with acute leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Leukemia

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Hyperglycemia, Leukemia | Phase 3 | Status: WITHDRAWN